EBF3early B-cell factor 3
Autism Reports / Total Reports
9 / 23Rare Variants / Common Variants
97 / 0Aliases
EBF3, COE3, EBF-3, HADDS, O/E-2, OE-2Associated Syndromes
-Chromosome Band
10q26.3Associated Disorders
DD/NDD, ID, ASDGenetic Category
Rare Single Gene Mutation, Syndromic, FunctionalRelevance to Autism
Heterozygous mutations in the EBF3 gene are associated with hypotonia, ataxia, and delayed development syndrome (HADDS; OMIM 617330), a neurodevelopmental syndrome characterized by congenital hypotonia, delayed psychomotor development, variable intellectual disability with speech delay, variable dysmorphic facial features, and ataxia, often associated with cerebellar hypoplasia (Sleven et al., 2017; Chao et al., 2017; Harms et al., 2017; Blackburn et al., 2017); individuals in Chao et al., 2017 were reported as presenting with perseverative social behaviors and motor stereotypies. Tanaka et al., 2017 described seven novel individuals with de novo EBF3 mutations; two of these individuals presented with autism, two individuals presented with autistic features, and two individuals presented with delayed or absent social smile. A de novo missense variant in the EBF3 gene was identified in an ASD proband from the Simons Simplex Collection in Iossifov et al., 2014; while this variant was novel (not present in dbSNP or ESP), it was predicted by PolyPhen-2 to be benign in Sanders et al., 2015. A de novo frameshift variant in the EBF3 gene was identified in an ASD proband from the Autism Sequencing Consortium in Satterstrom et al., 2020. Padhi et al., 2021 identified an excess of de novo variants in the enhancer hs737 in ASD probands [discovery (p =0.0172), replication (p = 2.5 103), and combined dataset (p = 1.1 104]; in vitro assessment of ASD-associated de novo variants in the hs737 enhancer demonstrated reduced enhancer activity in a neuronal cell line, and epigenomic analysis showed that hs737 was brain-specific and targeted the transcription factor gene EBF3 in human fetal brain. A phenotypic assessment of 41 individuals combined with a literature meta-analysis for a total of 83 individuals diagnosed with EBF3-related neurodevelopmental disorders in Deisseroth et al., 2022 found that autistic features were observed in 68% of the cohort, with a formal diagnosis of autism in 27% of the cohort; common autistic features included stereotypy (63%), poor eye contact (44%), noise aversion (53%) and an aversion to crowds (17%). Two de novo loss-of-function variants and four rare and potentially damaging missense variants in the EBF3 gene were reported in ASD probands from the SPARK cohort in Zhou et al., 2022; a two-stage analysis of rare de novo and inherited coding variants in 42,607 ASD cases, including 35,130 new cases from the SPARK cohort, in this report identified EBF3 as a gene reaching study-wide significance based on 5,754 constraint genes (P < 8.69E-06).
Molecular Function
This gene encodes a member of the early B-cell factor (EBF) family of DNA binding transcription factors. EBF proteins are involved in B-cell differentiation, bone development and neurogenesis, and may also function as tumor suppressors. The encoded protein inhibits cell survival through the regulation of genes involved in cell cycle arrest and apoptosis, and aberrant methylation or deletion of this gene may play a role in multiple malignancies including glioblastoma multiforme and gastric carcinoma.
External Links
SFARI Genomic Platforms
Reports related to EBF3 (23 Reports)
# | Type | Title | Author, Year | Autism Report | Associated Disorders |
---|---|---|---|---|---|
1 | Support | The contribution of de novo coding mutations to autism spectrum disorder | Iossifov I et al. (2014) | Yes | - |
2 | Support | De Novo Mutations in EBF3 Cause a Neurodevelopmental Syndrome | Sleven H , et al. (2016) | No | - |
3 | Support | A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3 | Chao HT , et al. (2016) | No | - |
4 | Support | Mutations in EBF3 Disturb Transcriptional Profiles and Cause Intellectual Disability, Ataxia, and Facial Dysmorphism | Harms FL , et al. (2016) | No | - |
5 | Support | Novel de novo variant in EBF3 is likely to impact DNA binding in a patient with a neurodevelopmental disorder and expanded phenotypes: patient report, in silico functional assessment, and review of published cases | Blackburn PR , et al. (2017) | No | - |
6 | Support | Whole Gene Deletion of EBF3 Supporting Haploinsufficiency of This Gene as a Mechanism of Neurodevelopmental Disease | Lopes F , et al. (2017) | Yes | DD, ID |
7 | Primary | De novo variants in EBF3 are associated with hypotonia, developmental delay, intellectual disability, and autism | Tanaka AJ , et al. (2017) | No | Autism or autistic features |
8 | Support | Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism | Satterstrom FK et al. (2020) | Yes | - |
9 | Support | Rare genetic susceptibility variants assessment in autism spectrum disorder: detection rate and practical use | Husson T , et al. (2020) | Yes | - |
10 | Support | - | Hildebrand MS et al. (2020) | No | DD |
11 | Support | - | Rodin RE et al. (2021) | Yes | - |
12 | Recent Recommendation | - | Padhi EM et al. (2021) | Yes | Hypotonia, ataxia, and delayed development syndrom |
13 | Support | - | Mahjani B et al. (2021) | Yes | - |
14 | Support | - | Ignatius E et al. (2021) | No | - |
15 | Support | - | Woodbury-Smith M et al. (2022) | Yes | - |
16 | Recent Recommendation | - | Deisseroth CA et al. (2022) | No | ASD or autistic features, ADHD, epilepsy/seizures |
17 | Support | - | Kepler LD et al. (2022) | No | - |
18 | Recent Recommendation | - | Zhou X et al. (2022) | Yes | - |
19 | Support | - | Zhu J et al. (2023) | No | ID, Afs, stereotypy |
20 | Support | - | Spataro N et al. (2023) | No | - |
21 | Support | - | Ciaccio C et al. (2023) | No | - |
22 | Support | - | Sanchis-Juan A et al. (2023) | No | - |
23 | Support | - | Axel Schmidt et al. (2024) | No | - |
Rare Variants (97)
Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Parental Transmission | Family Type | PubMed ID | Author, Year |
---|---|---|---|---|---|---|---|---|
- | - | copy_number_gain | Unknown | - | - | 36937983 | Zhu J et al. (2023) | |
- | - | copy_number_loss | De novo | - | - | 36937983 | Zhu J et al. (2023) | |
- | - | copy_number_loss | Unknown | - | - | 36937983 | Zhu J et al. (2023) | |
- | - | copy_number_loss | De novo | - | - | 37090941 | Ciaccio C et al. (2023) | |
- | - | copy_number_gain | De novo | - | - | 34999443 | Ignatius E et al. (2021) | |
- | - | copy_number_loss | De novo | - | - | 34999443 | Ignatius E et al. (2021) | |
- | - | copy_number_loss | Unknown | - | - | 35340043 | Deisseroth CA et al. (2022) | |
- | - | copy_number_loss | De novo | - | Simplex | 29062322 | Lopes F , et al. (2017) | |
c.636+1G>A | - | splice_site_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
A>G | - | intergenic_variant | De novo | - | Simplex | 34256850 | Padhi EM et al. (2021) | |
G>A | - | intergenic_variant | De novo | - | Simplex | 34256850 | Padhi EM et al. (2021) | |
T>C | - | intergenic_variant | De novo | - | Simplex | 34256850 | Padhi EM et al. (2021) | |
- | - | copy_number_loss | Unknown | - | Simplex | 37541188 | Sanchis-Juan A et al. (2023) | |
c.907C>T | p.Arg303Ter | stop_gained | De novo | - | - | 28017373 | Harms FL , et al. (2016) | |
c.913C>T | p.Gln305Ter | stop_gained | De novo | - | - | 28017373 | Harms FL , et al. (2016) | |
c.1101+1G>T | - | splice_site_variant | De novo | - | - | 28017373 | Harms FL , et al. (2016) | |
c.486-1G>A | - | splice_site_variant | De novo | - | - | 29162653 | Tanaka AJ , et al. (2017) | |
c.454C>T | p.Arg152Cys | missense_variant | Unknown | - | - | 36937983 | Zhu J et al. (2023) | |
c.164A>G | p.Glu55Gly | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.-19G>C | - | missense_variant | De novo | - | Simplex | 28017370 | Sleven H , et al. (2016) | |
c.616C>T | p.Arg206Ter | stop_gained | De novo | - | - | 29162653 | Tanaka AJ , et al. (2017) | |
c.422A>G | p.Tyr141Cys | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.482G>A | p.Cys161Tyr | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.49G>A | p.Glu17Lys | missense_variant | De novo | - | - | 33432195 | Rodin RE et al. (2021) | |
c.86C>A | p.Ser29Ter | stop_gained | De novo | - | - | 35340043 | Deisseroth CA et al. (2022) | |
c.1133T>A | p.Val378Glu | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.291+2del | - | splice_site_variant | De novo | - | - | 35340043 | Deisseroth CA et al. (2022) | |
c.554+1G>C | - | splice_site_variant | De novo | - | - | 35340043 | Deisseroth CA et al. (2022) | |
c.554+2T>G | - | splice_site_variant | De novo | - | - | 35340043 | Deisseroth CA et al. (2022) | |
c.805A>G | p.Ser269Gly | missense_variant | De novo | - | - | 34256850 | Padhi EM et al. (2021) | |
c.196A>G | p.Asn66Asp | missense_variant | De novo | - | - | 28017373 | Harms FL , et al. (2016) | |
c.422A>G | p.Tyr141Cys | missense_variant | De novo | - | - | 28017373 | Harms FL , et al. (2016) | |
c.512G>A | p.Gly171Asp | missense_variant | De novo | - | - | 28017373 | Harms FL , et al. (2016) | |
c.530C>T | p.Pro177Leu | missense_variant | De novo | - | - | 28017373 | Harms FL , et al. (2016) | |
c.485G>A | p.Ser162Asn | missense_variant | Unknown | - | - | 34615535 | Mahjani B et al. (2021) | |
c.422A>G | p.Tyr141Cys | missense_variant | De novo | - | - | 37090941 | Ciaccio C et al. (2023) | |
c.512G>A | p.Gly171Asp | missense_variant | De novo | - | - | 37090941 | Ciaccio C et al. (2023) | |
c.191A>C | p.Lys64Thr | missense_variant | De novo | - | - | 29162653 | Tanaka AJ , et al. (2017) | |
c.292-6T>G | - | splice_region_variant | De novo | - | - | 35340043 | Deisseroth CA et al. (2022) | |
c.232C>T | p.Gln78Ter | stop_gained | De novo | - | Simplex | 32094338 | Husson T , et al. (2020) | |
c.355+1G>C | - | splice_site_variant | De novo | - | Simplex | 28017370 | Sleven H , et al. (2016) | |
c.471C>A | p.His157Gln | missense_variant | De novo | - | - | 29162653 | Tanaka AJ , et al. (2017) | |
c.626G>A | p.Arg209Gln | missense_variant | De novo | - | - | 29162653 | Tanaka AJ , et al. (2017) | |
c.530C>T | p.Pro177Leu | missense_variant | De novo | - | - | 34999443 | Ignatius E et al. (2021) | |
c.625C>T | p.Arg209Trp | missense_variant | De novo | - | - | 34999443 | Ignatius E et al. (2021) | |
c.188G>A | p.Arg63Gln | missense_variant | De novo | - | Simplex | 36937983 | Zhu J et al. (2023) | |
c.422A>G | p.Tyr141Cys | missense_variant | De novo | - | Simplex | 36937983 | Zhu J et al. (2023) | |
c.487C>G | p.Arg163Gly | missense_variant | De novo | - | Simplex | 36937983 | Zhu J et al. (2023) | |
c.631T>C | p.Phe211Leu | missense_variant | De novo | - | Simplex | 36937983 | Zhu J et al. (2023) | |
c.-38_-37insCTTTCGGCC | - | inframe_insertion | De novo | - | - | 28017373 | Harms FL , et al. (2016) | |
c.656T>C | p.Val219Ala | missense_variant | De novo | - | - | 39039281 | Axel Schmidt et al. (2024) | |
c.-227_-224del | - | frameshift_variant | De novo | - | Simplex | 28017370 | Sleven H , et al. (2016) | |
c.291+1G>A | - | splice_site_variant | Familial | - | Multiplex | 36980980 | Spataro N et al. (2023) | |
c.487C>T | p.Arg163Trp | missense_variant | De novo | - | - | 28487885 | Blackburn PR , et al. (2017) | |
c.386G>C | p.Arg129Pro | missense_variant | De novo | - | - | 35340043 | Deisseroth CA et al. (2022) | |
c.422A>G | p.Tyr141Cys | missense_variant | De novo | - | - | 35340043 | Deisseroth CA et al. (2022) | |
c.469C>T | p.His157Tyr | missense_variant | De novo | - | - | 35340043 | Deisseroth CA et al. (2022) | |
c.471C>A | p.His157Gln | missense_variant | De novo | - | - | 35340043 | Deisseroth CA et al. (2022) | |
c.482G>A | p.Cys161Tyr | missense_variant | De novo | - | - | 35340043 | Deisseroth CA et al. (2022) | |
c.482G>T | p.Cys161Phe | missense_variant | De novo | - | - | 35340043 | Deisseroth CA et al. (2022) | |
c.487C>T | p.Arg163Trp | missense_variant | De novo | - | - | 35340043 | Deisseroth CA et al. (2022) | |
c.488G>A | p.Arg163Gln | missense_variant | De novo | - | - | 35340043 | Deisseroth CA et al. (2022) | |
c.492C>G | p.Cys164Trp | missense_variant | De novo | - | - | 35340043 | Deisseroth CA et al. (2022) | |
c.509G>A | p.Cys170Tyr | missense_variant | De novo | - | - | 35340043 | Deisseroth CA et al. (2022) | |
c.625C>T | p.Arg209Trp | missense_variant | De novo | - | - | 35340043 | Deisseroth CA et al. (2022) | |
c.626G>A | p.Arg209Gln | missense_variant | De novo | - | - | 35340043 | Deisseroth CA et al. (2022) | |
c.486-2_486-1inv | - | splice_site_variant | Unknown | - | - | 35340043 | Deisseroth CA et al. (2022) | |
c.1001T>G | p.Phe334Cys | missense_variant | De novo | - | - | 35340043 | Deisseroth CA et al. (2022) | |
c.488G>A | p.Arg163Gln | missense_variant | De novo | - | Simplex | 28017372 | Chao HT , et al. (2016) | |
c.488G>T | p.Arg163Leu | missense_variant | De novo | - | Simplex | 28017372 | Chao HT , et al. (2016) | |
c.1183C>T | p.His395Tyr | stop_gained | Familial | Maternal | - | 34999443 | Ignatius E et al. (2021) | |
c.872T>A | p.Leu291Ter | stop_gained | De novo | - | Simplex | 32345733 | Hildebrand MS et al. (2020) | |
c.1222del | p.Ile408SerfsTer27 | frameshift_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.530C>T | p.Pro177Leu | missense_variant | De novo | - | Simplex | 28017370 | Sleven H , et al. (2016) | |
c.579G>T | p.Lys193Asn | missense_variant | De novo | - | Simplex | 28017370 | Sleven H , et al. (2016) | |
c.49G>A | p.Glu17Lys | splice_site_variant | De novo | - | Simplex | 28017370 | Sleven H , et al. (2016) | |
c.151_153delinsTGA | p.Arg51Ter | stop_gained | De novo | - | - | 35340043 | Deisseroth CA et al. (2022) | |
c.174G>A | p.Pro58%3D | synonymous_variant | Unknown | - | - | 35205252 | Woodbury-Smith M et al. (2022) | |
c.481del | p.Cys161AlafsTer21 | frameshift_variant | De novo | - | - | 37090941 | Ciaccio C et al. (2023) | |
c.244del | p.Val82TrpfsTer50 | frameshift_variant | De novo | - | - | 29162653 | Tanaka AJ , et al. (2017) | |
c.1496G>C | p.Gly499Ala | missense_variant | De novo | - | Simplex | 25363768 | Iossifov I et al. (2014) | |
c.292-6T>G | - | splice_region_variant | Familial | Maternal | - | 35340043 | Deisseroth CA et al. (2022) | |
c.291del | p.Glu98SerfsTer34 | frameshift_variant | De novo | - | - | 35340043 | Deisseroth CA et al. (2022) | |
c.305G>A | p.Glu102Gly | missense_variant | Familial | Paternal | - | 35340043 | Deisseroth CA et al. (2022) | |
c.488G>C | p.Arg163Pro | missense_variant | Familial | Maternal | - | 35340043 | Deisseroth CA et al. (2022) | |
c.481del | p.Cys161AlafsTer21 | frameshift_variant | De novo | - | - | 35340043 | Deisseroth CA et al. (2022) | |
c.779del | p.Ser260IlefsTer15 | frameshift_variant | De novo | - | - | 35340043 | Deisseroth CA et al. (2022) | |
c.1040G>A | p.Gly347Asp | missense_variant | Familial | Paternal | - | 35340043 | Deisseroth CA et al. (2022) | |
c.840dup | p.Asp281Ter | frameshift_variant | De novo | - | Simplex | 31981491 | Satterstrom FK et al. (2020) | |
c.1402_1414del | p.Thr468ProfsTer10 | frameshift_variant | De novo | - | - | 29162653 | Tanaka AJ , et al. (2017) | |
c.625C>T | p.Arg209Trp | missense_variant | Familial | Maternal | Multiplex | 28017373 | Harms FL , et al. (2016) | |
c.280_283del | p.Glu94LysfsTer37 | frameshift_variant | Unknown | - | Simplex | 37541188 | Sanchis-Juan A et al. (2023) | |
c.616C>T | p.Arg206Ter | stop_gained | De novo (germline mosaicism) | - | Multiplex | 28017370 | Sleven H , et al. (2016) | |
c.663_685del | p.Asp222ArgfsTer34 | frameshift_variant | Familial | Maternal | Simplex | 34256850 | Padhi EM et al. (2021) | |
c.560_563del | p.Phe187Ter | frameshift_variant | Familial | Maternal | Multiplex | 35340043 | Deisseroth CA et al. (2022) | |
c.1581_1582del | p.Met528GlyfsTer12 | frameshift_variant | Familial | - | Extended multiplex | 34256850 | Padhi EM et al. (2021) | |
c.622dup | p.Met208AsnfsTer56 | frameshift_variant | Familial | Maternal | Extended multiplex | 34999443 | Ignatius E et al. (2021) |
Common Variants
No common variants reported.
SFARI Gene score
High Confidence, Syndromic
Score Delta: Score remained at 1S
criteria met
See SFARI Gene'scoring criteriaWe considered a rigorous statistical comparison between cases and controls, yielding genome-wide statistical significance, with independent replication, to be the strongest possible evidence for a gene. These criteria were relaxed slightly for category 2.
The syndromic category includes mutations that are associated with a substantial degree of increased risk and consistently linked to additional characteristics not required for an ASD diagnosis. If there is independent evidence implicating a gene in idiopathic ASD, it will be listed as "#S" (e.g., 2S, 3S, etc.). If there is no such independent evidence, the gene will be listed simply as "S."
1/1/2021
Score remained at 1
Description
Heterozygous mutations in the EBF3 gene are associated with hypotonia, ataxia, and delayed development syndrome (HADDS; OMIM 617330), a neurodevelopmental syndrome characterized by congenital hypotonia, delayed psychomotor development, variable intellectual disability with speech delay, variable dysmorphic facial features, and ataxia, often associated with cerebellar hypoplasia (Sleven et al., 2017; Chao et al., 2017; Harms et al., 2017; Blackburn et al., 2017); individuals in Chao et al., 2017 were reported as presenting with perseverative social behaviors and motor stereotypies. Tanaka et al., 2017 described seven novel individuals with de novo EBF3 mutations; two of these individuals presented with autism, two individuals presented with autistic features, and two individuals presented with delayed or absent social smile. A de novo missense variant in the EBF3 gene was identified in an ASD proband from the Simons Simplex Collection in Iossifov et al., 2014; while this variant was novel (not present in dbSNP or ESP), it was predicted by PolyPhen-2 to be benign in Sanders et al., 2015.
1/1/2020
Score remained at 1
Description
Heterozygous mutations in the EBF3 gene are associated with hypotonia, ataxia, and delayed development syndrome (HADDS; OMIM 617330), a neurodevelopmental syndrome characterized by congenital hypotonia, delayed psychomotor development, variable intellectual disability with speech delay, variable dysmorphic facial features, and ataxia, often associated with cerebellar hypoplasia (Sleven et al., 2017; Chao et al., 2017; Harms et al., 2017; Blackburn et al., 2017); individuals in Chao et al., 2017 were reported as presenting with perseverative social behaviors and motor stereotypies. Tanaka et al., 2017 described seven novel individuals with de novo EBF3 mutations; two of these individuals presented with autism, two individuals presented with autistic features, and two individuals presented with delayed or absent social smile. A de novo missense variant in the EBF3 gene was identified in an ASD proband from the Simons Simplex Collection in Iossifov et al., 2014; while this variant was novel (not present in dbSNP or ESP), it was predicted by PolyPhen-2 to be benign in Sanders et al., 2015.
10/1/2019
Increased from S to 1
New Scoring Scheme
Description
Heterozygous mutations in the EBF3 gene are associated with hypotonia, ataxia, and delayed development syndrome (HADDS; OMIM 617330), a neurodevelopmental syndrome characterized by congenital hypotonia, delayed psychomotor development, variable intellectual disability with speech delay, variable dysmorphic facial features, and ataxia, often associated with cerebellar hypoplasia (Sleven et al., 2017; Chao et al., 2017; Harms et al., 2017; Blackburn et al., 2017); individuals in Chao et al., 2017 were reported as presenting with perseverative social behaviors and motor stereotypies. Tanaka et al., 2017 described seven novel individuals with de novo EBF3 mutations; two of these individuals presented with autism, two individuals presented with autistic features, and two individuals presented with delayed or absent social smile. A de novo missense variant in the EBF3 gene was identified in an ASD proband from the Simons Simplex Collection in Iossifov et al., 2014; while this variant was novel (not present in dbSNP or ESP), it was predicted by PolyPhen-2 to be benign in Sanders et al., 2015.
Reports Added
[New Scoring Scheme]Krishnan Probability Score
Score 0.53132184844142
Ranking 1539/25841 scored genes
[Show Scoring Methodology]
ExAC Score
Score 0.99859001376164
Ranking 1157/18225 scored genes
[Show Scoring Methodology]
Sanders TADA Score
Score 0.94010716308957
Ranking 14448/18665 scored genes
[Show Scoring Methodology]
Zhang D Score
Score -0.35346458549528
Ranking 17858/20870 scored genes
[Show Scoring Methodology]